MENU
IKT
AS OF
Dec 12 closing price
Price
$1.54
Change
+$0.02 (+1.32%)
Capitalization
186.75M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
IKT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Inhibikase Therapeutics (IKT) Ownership - Who owns Inhibikase Therapeutics?

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease (PD), Parkinson’s-related disorders and other diseases of the Abelson Tyrosine Kinases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
3350 Riverwood Parkway SE
Phone
+1 678 392-3419
Employees
14
Web
https://www.inhibikase.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
186.75M
P/E Ratio
3.28
Total Cash
77.32M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.96
Dividend Yield
N/A
Total Cash/Share
0.64
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

IKT
Capitalization
187M
P/E Ratio
3.28
Risk (Beta)
0.96
Dividend Yield
N/A
Total Cash
77.3M
Total Cash/Share
0.64
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
72.9M
P/B Ratio
2.56
Cash Flow
N/A
Earnings
0.47
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
74.8K
Current Ratio
11.73
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-53.08M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-113.51
Shares Held By Institutions
101M
Shares Outstanding - Current
121M
Total Liabilities
6.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-53.077
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IKT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for IKT
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3350 Riverwood Parkway SE
Phone
+1 678 392-3419
Employees
14
Web
https://www.inhibikase.com